Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HEXA | P06865 | 1/20 | 0.33 |
| ▸ | HEXB | P07686 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3246174 | 0.81 | DHFR (0.42) | RAB9ASMN1; SMN2CYP1A2TSHRALDH1A1 | |
| SCHEMBL3240709 | 0.78 | PDE4B (0.37) | RAB9AALDH1A1KDM4EMEN1LMNA | |
| SCHEMBL2530469 | 0.71 | ALDH1A1 (0.50) | NPC1RAB9ASMN1; SMN2CASP3SENP8 | |
| SCHEMBL4265966 | 0.70 | PDK2 (0.44) | NPC1RAB9ASMN1; SMN2CASP3SENP8 | |
| SCHEMBL23367880 | 0.69 | MAP2 (0.43) | NPC1RAB9ASMN1; SMN2CASP3SENP8 | |
| SCHEMBL22812427 | 0.67 | MEN1 (0.40) | NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19 | |
| SCHEMBL10682793 | 0.67 | MEN1 (0.47) | NPC1RAB9ASMN1; SMN2CASP3SENP8 | |
| SCHEMBL17924589 | 0.67 | KCNA3 (0.40) | NPC1RAB9ASMN1; SMN2CASP3SENP8 | |
| SCHEMBL1133067 | 0.67 | MYC (0.56) | NPC1RAB9ASMN1; SMN2CASP3SENP8 | |
| SCHEMBL197690 | 0.65 | ACHE (0.64) | NPC1RAB9ASMN1; SMN2CASP3SENP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1225163-B1 | Process for producing isopulegol | TAKASAGO PERFUMERY CO LTD (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-6774269-B2 | CYCLIZATION OF CITRONELLAL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-08-10 | — | — | US | disclosed |
| US-20020133046-A1 | Process for producing isopulegol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-19 | — | — | US | disclosed |
| EP-1225163-A2 | Process for producing isopulegol | Takasago International Corporation (JP) | 2002-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133046-A1 | Process for producing isopulegol | ACSL3, ACSL1, ACSL6 | NPC1 2244/4885RAB9A 3495/4885SMN1; SMN2 3034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.